Preventing Depression Relapse With Mindfulness-Based Cognitive Therapy

• Status: Completed
• Trial end date: 2010-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will determine the effectiveness of mindfulness-based cognitive therapy (MBCT) in preventing depression relapse.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre for Addiction and Mental Health
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Antidepressive Agents

Criteria

Inclusion Criteria:

• Meet DSM criteria for recurrent major depressive disorder, defined as at least one major depressive episode within 3 years prior to study entry AND at least 2 months of normal functioning following the episode

Exclusion Criteria:

• Depression secondary to a concurrent medical disorder

• Current use of medication that could cause depressive symptoms

• A rating of level 2 or higher on the Index of Treatment Refractory Depression

• Current diagnosis of any of the following psychiatric disorders: psychotic or organic mental, bipolar, primary obsessive compulsive, borderline personality, antisocial personality, or eating

• Current diagnosis of comorbid chronic depression that is disabling

• Current substance abuse

• Score less than 14 on the Hamilton Rating Scale for Depression-17 (HRSD-17)

• At risk for suicide

• Pregnancy or plan to become pregnant during the study

• Practice meditation more than once a week or yoga more than twice a week at study entry